Mutz I, Urban C, Gadner H, Jürgenssen O A, Zoubek A
Padiatr Padol. 1986;21(3):269-74.
During the period from 1979 until 1984 55 children were registered: 4 in Evan-stage I, 13 in stage II, 16 in stage III, 18 in stage IV and 4 in stage IV-S. 39 of these 55 patients have been followed for a minimum of two years. The current two year survival rate is 10/10 in stages I and II, 6/13 in stage III, 3/14 in stage IV and 2/2 in stage IV-S. These results demonstrate but a slight improvement in patients with stage II since the last Austrian statistic 1974. Despite modern chemotherapy the chance for survival of children with stage III or IV neuroblastoma is poor and better treatment modalities should be searched for.
1979年至1984年期间,登记在册的儿童有55名:埃文一期4名,二期13名,三期16名,四期18名,四期-S 4名。这55名患者中有39名至少随访了两年。目前,一期和二期的两年生存率为10/10,三期为6/13,四期为3/14,四期-S为2/2。这些结果表明,自1974年奥地利上一次统计以来,二期患者的情况仅有轻微改善。尽管有现代化疗方法,但三期或四期神经母细胞瘤患儿的生存机会仍然很低,应该寻找更好的治疗方式。